Applications of 2-Fluoro-3-Methylpyridine-5-Boronic Acid in Industrial Manufacturing

2-Fluoro-3-methylpyridine-5-boronic acid, as a specialty boronic acid derivative, has demonstrated precise and reliable roles as a coupling intermediate in regulated industrial synthesis, primarily within the pharmaceutical, crop protection, and advanced material sectors. The compound’s functional group arrangement permits high selectivity for key palladium-catalyzed C-C bond formations, positioning it as an essential input for the manufacture of critical downstream molecules. As the direct manufacturer, we control the entire production chain, allowing for batch-specific technical support to end-users in each application segment described below.

1. Pharmaceutical API Synthesis: Pyridine-Based Oncology Drugs

This boronic acid finds established use in the pharmaceutical sector for the synthesis of fluorinated pyridine motifs present in next-generation kinase inhibitors and other oncology actives. End manufacturers rely on the compound for its stability under Suzuki-Miyaura cross-coupling, enabling selective introduction of the fluoro-methylpyridine fragment into advanced intermediates. The purity and trace impurity profile meet stringent requirements as demanded by global drug authorities.

Industry compliance standards

• ICH Q7A (Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients)
• US FDA 21 CFR Parts 210/211
• European Pharmacopoeia (Ph. Eur.) monographs for raw materials
• Certificate of Suitability (CEP) prerequisites for starting materials

Typical usage ratio

• 0.8–1.3 equivalents relative to aryl halide reactant in API intermediate coupling; adjusted based on desired conversion and minimization of post-reaction boronic ester hydrolysis byproducts.

Downstream process integration

• Added directly during Suzuki coupling at the advanced intermediate stage (Step 4–8 of API synthesis route); subsequent steps include deprotection, purification, and crystallization under GMP controls.

Final product types

• Pyridine-based kinase inhibitors (e.g., precursors to ALK, BTK, or EGFR inhibitors)
• Fluorinated heterocycle oncology APIs
• Late-stage pharmaceutical intermediates proprietary to branded formulations

2. Agrochemical Intermediate Manufacturing: Pyridine Herbicide Precursors

Chemical process plants engaged in crop protection synthesis utilize the compound to construct fluorinated pyridine rings integral to modern herbicide scaffolds. The material’s boronic acid functionality allows efficient assembly of target molecules via cross-coupling without introducing secondary halides, reducing downstream purification burdens and regulatory reporting of halogenated by-products.

Industry compliance standards

• FAO/WHO Technical Specifications for Pesticides
• OECD Good Laboratory Practice (GLP) for chemical synthesis records
• EU Regulation (EC) No 1107/2009 (Plant protection product approval)
• ISO 9001:2015 certified quality management systems

Typical usage ratio

• 1–1.2 molar equivalents per active aryl halide, tuned to maximize coupling conversion and limit excess boronic acid carryover into mother liquors.

Downstream process integration

• Introduced during the coupling step in herbicide intermediate formation, typically followed by functional group modification (e.g., chlorination, esterification); trailed by solvent swap and active ingredient isolation.

Final product types

• Precursors for selective broadleaf herbicides with pyridine moieties
• Building blocks for pyridinyl-amide crop protection agents
• Active ingredients for global agchem product registrations

3. OLED Material Synthesis: Fluorinated Ligand Construction

Specialty electronics materials manufacturers exploit the compound’s boronic acid group in the assembly of functionalized pyridine ligands used in organic light-emitting diode (OLED) emitters. The high coupling efficiency under controlled anhydrous conditions supports the creation of electron transport layers and color tuning fragments for display applications. Strict impurity control enables compliance with electronic-grade raw requirements.

Industry compliance standards

• IEC 61249-2-41: Material specification for electronic assemblies
• RoHS Directive 2011/65/EU (Restriction of Hazardous Substances)
• Internal display panel manufacturer standards for low ionic and metallic impurities
• ISO 9001:2015 for electronic precursor quality

Typical usage ratio

• 1.0 equivalent compared to aryl halide; precisely weighed at 0.95–1.05 molar ratio to optimize product yield and maintain stringent impurity thresholds required by display device integrators.

Downstream process integration

• Used in the palladium-mediated cross-coupling (Suzuki) stage for the generation of pyridine-functionalized ligands; integrated into multi-step batch or continuous flow substrate functionalization workflows prior to emitter purification.

Final product types

• Complex fluorinated pyridine ligands for OLED emitters
• Electron transport materials for display panel construction
• Precursor monomers for light-emitting and charge transport polymers

4. Active Ingredient Intermediate for Veterinary Pharmaceuticals

Manufacturers of veterinary pharmaceuticals utilize this compound as a coupling intermediate for the generation of fluorinated pyridine cores present in API candidates targeting animal health. Direct incorporation into synthetic workflows enables efficient diversification of lead structures and supports robust impurity profiling, critical to regulatory submission packages for ingestion or injectable formulations used in livestock species.

Industry compliance standards

• VICH GL22 (Good Manufacturing Practices for Active Pharmaceutical Ingredients)
• US FDA CVM Guidances for New Animal Drugs
• European Medicines Agency (EMA) Veterinary Requirements
• ISO 9001:2015 for animal drug production inputs

Typical usage ratio

• 0.9–1.2 equivalents per halogenated partner in lead structure synthesis; ratio adjusted to minimize unreacted starting material and facilitate downstream chromatographic separation.

Downstream process integration

• Charged into Suzuki coupling during pre-final API intermediate steps, before transformation and salt formation; integration point governed by target molecule’s synthetic route and required regulatory documentation.

Final product types

• Fluoro-pyridine veterinary active ingredients for antiparasitic, antibiotic, or anti-inflammatory drugs
• Proprietary API intermediates for commercial animal product launches
• Lead development candidates for livestock health

5. Discovery Chemistry: Structure-Activity Relationship (SAR) Optimization

Research units and contract development manufacturing organizations (CDMOs) employ this boronic acid in building SAR libraries, enabling rapid diversification of fluorinated pyridine analogs for pharmaceutical and agricultural lead optimization. Its documented reactivity under a range of Suzuki conditions provides chemists with reliable input control and traceability in low- to medium-scale parallel synthesis, directly impacting downstream candidate selection and patent application submissions.

Industry compliance standards

• OECD Principles of Good Laboratory Practice (GLP)
• Company-specific analytical method validation SOPs
• US FDA cGMP (where transitioning from R&D to pilot scale)
• ISO 17025:2017 for accredited analytical laboratories

Typical usage ratio

• Ranges from 0.8 to 1.5 equivalents, depending on scale (milligram for SAR screening, up to kilograms for advanced hits); ratio selection balances conversion efficiency and cost of goods for iterative optimization campaigns.

Downstream process integration

• Fed into high-throughput Suzuki coupling or small-scale batch libraries; followed by rapid purification and direct use in bioassays or physicochemical property evaluation.

Final product types

• SAR libraries of fluorinated pyridine analogs
• Screening hits for pharma/agro lead generation programs
• Patentable molecular scaffolds prepared for IP filings